News
Latest News
Washington, D.C. (July 14, 2021)— Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Committee Members Rep. Robin Kelly and Rep. Cori Bush released a new Government Accountability Office (GAO) report on the public health impact of America's gun violence epidemic. Senator Elizabeth Warren and Senator Ed Markey joined the Members in highlighting the report and calling for Congress to act to protect Americans from gun violence.
Washington, D.C. (July 14, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep.
WASHINGTON – U.S. Senator Ben Cardin and Congressman Anthony G.
Washington, D.C. (July 13, 2021)— Today, Rep. Gerry Connolly, Chairman of the Subcommittee on Government Operations, sent a letter to President Biden urging him to prioritize the appointment of a new Inspector General at the Federal Housing Finance Agency (FHFA), following the resignation of Inspector General Laura Wertheimer.
| Washington, D.C. (July 13, 2021)—On Wednesday, July 14, 2021 at 2:00 p.m. ET, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Committee Members Rep. Robin Kelly and Rep. Cori Bush, will hold a press conference to release a new Government Accountability Office (GAO) report on the public health impact of America's gun violence epidemic. |
Washington D.C. (July 12, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. Frank Pallone, Jr., Chairman of the Committee on Energy and Commerce, sent a letter to Biogen Inc. Chief Executive Officer Michel Vounatsos requesting documents related to the approval process, marketing, and pricing of Biogen's Alzheimer's drug, Aduhelm.
Washington D.C. (July 9, 2021)— Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Rep. Frank Pallone, Jr., Chairman of the Committee on Energy and Commerce, issued a joint statement following news that Food and Drug Administration (FDA) Acting Commissioner Janet Woodcock has requested the Department of Health and Human Services (HHS) Office of Inspector General (OIG) review the interactions between Biogen and FDA during the process leading to approval of Biogen's Alzheimer's drug Aduhelm:
Washington, D.C. (July 8, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and senior Committee Member Rep. Mark DeSaulnier, issued this statement following news that additional state Attorneys General reached an agreement with Purdue Pharma on a bankruptcy settlement:
Washington, D.C. (July 7, 2021)—On Thursday, July 8, 2021, at 2:00 p.m. ET, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, will hold a press conference with Speaker Nancy Pelosi and advocates to release a new Oversight and Reform Committee staff report analyzing the financial data of 14 of the largest drug companies in the world to evaluate the amount they spend to enrich investors and executives, the amount they invest to research and develop new treatments, and the potential impact of direct Medicare price negotiations.